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Objective: To review the effects ofmethylphenidate on cognitive enhancement,memory, and
performance in medical students.
Methods: A review of four databases (LILACS, PubMed, ScienceDirect, and SciELO), analyzing
the title and abstract of all articles published between 1990 and 2012 in English, Portuguese,
and Spanish. Selected articles were read in entirety, including in the review those that met
the established criteria.
Results: The prevalence of use among medical students reached 16%, with no gender dif-
ference. Most students began using the drug after entering the university, and the reasons
cited to justify it are related to enhancing academic performance.
Conclusion: There is no evidence in the literature that the use of methylphenidate is beneﬁ-
cial in terms of memory or learning. The drug simply increases wakefulness and alertness,
reducing the time of sleep.
© 2013 Elsevier Editora Ltda.
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Objetivo: Revisar o uso de metilfenidato em estudantes de medicina hígidos, abordando a
prevalência, variáveis demográﬁcas,motivos e possívelmelhora do desempenho acadêmico
desta populac¸ão.
Métodos: Realizou-se uma revisão nas bases de dados LILACS, PubMed, ScienceDirect e Sci-
ELO, analisando-se o título e resumo de todos os artigos publicados entre 1990 e 2012 nos
idiomas inglês, português e espanhol. Os artigos selecionados foram lidos de forma integral,
incluindo-se na revisão aqueles que atenderam aos critérios determinados.
Resultados: A prevalência do uso em estudantes de medicina chega a 16%, não havendo
diferenc¸a entre os gêneros. A maioria dos alunos iniciou o uso após ingresso no nível supe-
rior e os motivos citados para justiﬁcá-lo estão relacionados à melhora do desempenho
acadêmico.
 Study conducted at Universidade de Caxias do Sul, Caxias do Sul, RS, Brazil.
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Conclusão: Não existe evidência na literatura contemporânea que o uso de metilfenidato
é benéﬁco em relac¸ão à memória ou aprendizagem. A droga apenas torna o usuário mais
desperto e alerta, reduzindo o tempo de sono.
© 2013 Elsevier Editora Ltda.
Introduction
The university is an environment that encourages learn-
ing and research to develop science. Higher education thus
requires a high level of work and dedication by students,
especially in medical school. After six years at university,
graduating medical students have to undergo an exam to
qualify for a residency. This makes medical school highly
competitive.1
Under these circumstances, healthy college students have
been using psychoactive substances to allow them to study for
longer hours and to optimize their academic efﬁciency.2
Stimulant drugs are used to increase energy level and con-
centration, diminishing the need for rest. The most often
used medicine is methylphenidate hydrochloride, which sti-
mulates the central nervous system (CNS) and acts by blocking
dopamine reuptake and by releasing dopamine and nore-
pinephrin into the synaptic space. In Brazil, this drug is
commercializedasRitalin® (Novartis) andConcerta® (Janssen-
Cilag).3,4
Legal indications for the use of methylphenidate are
restricted to children diagnosed with attention deﬁcit and
hyperactivity disorder (ADHD) in whom the drug improves
attention. The United Nation’s 1971 Psychotropic Substances
Convention classiﬁedmethylphenidate as a psychotropic drug
with a risk of abuse and dependence, hence its prescription is
controlled.3,5
Due its probable beneﬁt to cognition, methylphenidate is
frequently used for non-medical reasons, mainly among uni-
versity students, since university requires a high standard of
work and the students must stay awake for longer periods.1,6
Objectives
The main objective of this article is to review the usage of
methylphenidate in healthy medical students, addressing the
prevalence, demographic variables, reasons for use, and pos-
sible beneﬁcial effect on academic performance.
Methods
A systematic research was performed in four databases
(LILACS, PubMed, ScienceDirect, and SciELO), including all
articles published between 1990 and 2011 written in English,
Portuguese, or Spanish. The key words used for the research
were “Methylphenidate”, “Ritalin”, “Methylphenidate”
AND/OR “Students”, “Methylphenidate” AND/OR “College
students”, “Methylphenidate” AND/OR “Medical students”,
“Ritalin” AND/OR “Students”, “Ritalin” AND/OR “College
students”, “Ritalin” AND/OR “Medical students”.
The following exclusion criteria were applied: publication
before 1990, case reports, series case reports, articles that ana-
lyzed populations other than college students, and articles
that did not analyze methylphenidate.
Articles included in the study were analyzed concerning
the prevalence of psycho-stimulating drug abuse, demo-
graphic variables among users (gender, age, undergraduates
or graduates), reasons for use, possible beneﬁts, period in
which methylphenidate use began, route of administration,
and knowledge about the drug.
Results
The total number of articles retrieved using the keyword
results of four databases was 875. Five of the articles were
found in LILACS, 38 in SciELO, 93 in PubMed, and 739 in Sci-
enceDirect (Table 1).
The title and abstract of these articles were analyzed, and
those that did not discuss the proposed topic were excluded.
A total of 21 articles were selected and thoroughly analyzed
according to the exclusion criteria. 12 articles did not meet
the criteria and were excluded (Fig. 1), resulting in the inclu-
sion of nine articles in this review: one from LILACS, three
from SciELO, four from PubMed, and one from ScienceDirect
(Table 2).
Prevalence
Studies that evaluated use of methylphenidate at least once
in lifetime identiﬁed a prevalence between 8.3% and 9%, while
for those studies that asked questions about use in the last
year, the prevalence ranged from 3% to 16%.1,2,5–7 In one of
the articles, 14.5% of medical students answered positively to
the question “Have you ever usedmethylphenidate to improve
academic performance?”.7
854 were not related to
methylphenidate and
students
21 potentially
eligible articles
Nine included
Two did not include methylphenidate
One did not analyze learning effects
Two case series reports
One did not include students
One did not include college students
One qualitative article
Two pharmacodynamics articles 
875 analyzed
articles
Fig. 1 – Research results.
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Table 1 – Number of articles found in each database.
LILACS SciELO PubMed ScienceDirect
Methylphenidate 5 38 6,200 13,785
Methylphenidate + college students 2 0 30 1,091
Methylphenidate + students 2 1 93 2,889
Methylphenidate + medical students 0 0 7 739
Ritalin 3 3 6,250 2,244
Ritalin + college students 1 1 30 315
Ritalin + students 0 0 94 669
Ritalin + medical students 0 0 7 251
Demographic variables
Regarding gender, results vary according to the study. Teter
et al.1 didnot identify adifferencebetweenmales and females.
Bogle et al.,8 however, noticedahigherprevalenceamongmale
college students, while dos Santos et al.9 identiﬁed a higher
prevalence in females.
As to ethnicity, a higher prevalence was found among
whites (7%), followed by Asians and blacks.1,8
The correlation between the use of methylphenidate and
average academic grades showed a greater prevalence of use
in the group of students with a lower grade average.6
Reasons
College students use CNS stimulating agents for recreational
reasons in order to increase time awake and disposition for
leisure, to lose weight, and ﬁnally to enhance cognitive per-
formance and, consequently, to improve professional and
academic achievement.3
According to Teter et al., the main motives for the illicit
use of methylphenidate are to improve concentration (65.2%),
help studying (59.8%), and increasewakefulness (47.5%). Other
reasons described were recreational as narcotics (31%), exper-
imentation (29.9%), and to stay awake.1
According to Habibzadeh,6 who evaluated medical stu-
dents in Iran, 41.7% of thosewho usedmethylphenidate did so
in order to help concentration. Other reasons for using were,
in decreasing order of importance: to stay alert, for curiosity,
to have more energy, to have higher self-conﬁdence, due to
environmental pressure, and to lose weight.
Results of an American review performed in Maryland
show that the reasons for using methylphenidate included
better intellectual performance (23%) and for greater efﬁciency
while performing academic tasks (22%).5
According to a study by Uregon,7 at Manizales Univer-
sity the most frequent reasons to consume methylphenidate
are, in decreasing order: personal pleasure, social pressure,
curiosity, friends’ inﬂuence, to avoid fatigue, and ﬁnally
for recreational reasons. Other reasons cited in the article
include use in order to lose weight, and the association of
methylphenidate use with alcoholic beverages.1,4
Beneﬁts
A single dose use of methylphenidate showed beneﬁts for
memory; however, this result is not maintained after pro-
longedabuseof thedrug.Other outcomesoftenanalyzed, such
as attention, mood, and executive functions, did not show any
difference when comparing students who used the drug with
others who denied use.4
Initial use
When students were asked at what time they began to
use the medication, most of them (65.2%) reported that the
ﬁrst time was during college. Only 34.8% had already used
methylphenidate before attending university. It is notewor-
thy that these groups have different reasons for using the
drug. Those who began to use methylphenidate during college
describe an academic purpose, such as increased concentra-
tion and to help studying. On the other hand, the group that
began to use methylphenidate before college did that as a
narcotic, to lose weight, or even to discover its effect.1
Among the students who used methylphenidate for the
ﬁrst time during college, its use varied during the school year.
Periods close to exams or the end of semester, due to ﬁnal
exams, are associated with a higher demand for prescrip-
tion stimulants, especially methylphenidate.6 In the article by
Mazzoglio et al., when only the group that reported the use
of stimulating substances was analyzed, 65% reported that
they start studying the subject in the last three days before
the exam.2
Administration routes
Methylphenidate has different forms of commercialization,
of which pills or liquid solution, which can be administered
intravenously or nasally, are highlighted. Among these dif-
ferent types and routes of administration, pills are the most
Table 2 – Article analysis for inclusion.
LILACS SciELO PubMed ScienceDirect Total
Total articles 5 38 93 739 875
Selected articles 2 3 8 8 21
Included articles 1 3 4 1 9
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common for non-medical conditions, corresponding to 95.3%
of use. Next, in terms of prevalence, is the nasal route; the
least common route is intravenously.1,6
Discussion
Neural enhancement is a term used to describe improve-
ment of cognitive, emotional, and motivational functions in
healthy subjects, acquired by different types of intervention. If
this enhancement is achieved by psychopharmaceutical sub-
stances, it is called pharmacologic neuroenhancement.4
Pharmacological neuroenhancement has increased in the
academic environment, mainly among college students, to
such an extent that the use of psychostimulating drugs to
improve academic performance is considered a public health
problem in various countries.1,7 American data from 2003 esti-
mated that 4.1 million people above the age of 12 had already
used methylphenidate at least once in their lifetime without
a medical prescription.5 Moreover, drug production and con-
sumption has steeply increased in the last decades. According
to the UnitedNations report on the production of agents,10 the
worldwide production of methylphenidate increased from 2.8
tonnes in 1990 to, almost, 38 tonnes in 2006, and the United
States was the main producer and consumer.
In Brazil, consumption has also increased over the years.
In 2000, the Brazilian national consumption was around 23kg,
and the Brazilian production increased from 40kg in 2002
to 226kg in 2006.11 Unofﬁcial information conveyed in non-
scientiﬁc media shows that this major rise turned Brazil into
the second leading in the world for methylphenidate prescrip-
tion.
Nevertheless, there is little Brazilian medical literature on
this subject, with few articles published in specialized maga-
zines. In Brazil, this subject is more widely discussed in the
lay media than in scientiﬁc literature. The media publishes
texts based on a single specialized opinion, or on the ideas of
non-specialized people, without any scientiﬁc foundation to
allow for consistent conclusions about the Brazilian national
standard of use.3
Stimulants vary according to their pharmacokinetic and
pharmacodynamic properties, and their beneﬁts for patients
diagnosed with ADHD are incorrectly extrapolated to healthy
individuals who aim for a better academic performance.
Methylphenidate is a CNS-stimulating agent whose use with-
out a medical prescription has increased steeply.
A non-medical use of a neurostimulating drug is deﬁned
as the use of a drug prescribed by a doctor, but at a differ-
ent dosage than recommended, or drug use by a different
person who does not have a medical prescription.5 The sec-
ond deﬁnition includes most college students who admitted
to methylphenidate abuse in order to enhance academic per-
formance, and increase concentration and alertness.6
Current literature does not allow for a deﬁnite conclusion
on the potential beneﬁts of this medicine in non-ADHD sub-
jects. Existing studies does not show consistent evidence of
the optimizing effects on the CNS; however, one article sug-
gests a positive effect of methylphenidate on the working
memory.4
Contrary to popular and college students’ beliefs, there is
no evidence that methylphenidate increases attention. Atten-
tion is deﬁned as a proper allocation of mental procedural
resources in response to relevant stimuli.4 It is believed that
the effect of methylphenidate to better target and focus on
stimuli occurs due to the greater release of dopamine in the
CNS.
One of the possible reasons for the low efﬁciency of
methylphenidate as a neuroenhancement drug for healthy
individuals is that most studies used 12m to 20mg doses. This
is probably a sub-dose for the expected effects of the drug.
However, there is no scientiﬁc study comparing the effects
of different doses on academic performance.4 In pathologies
in which methylphenidate is proven beneﬁcial, the indicated
dosage is 20mg to 30mg a day in patientswho suffer fromnar-
colepsy, and the dose can be increased until a limit of 40mg
to 60mg a day. In children with a diagnosis of ADHD, the ini-
tial dose is approximately 5mg to 10mg daily, and in cases
that require higher doses, it should be gradually raised to a
maximum of 60mg a day.
Another probable cause of failing in academic enhance-
ment is the fact that the drug is mostly used three days before
the tests. This method of studying impairs academic perfor-
mance, since the amount of information to which the student
is exposed during the period just before exams is higher than
the amount that they are able to acquire in such a short time.2
Besides, stimulating agents, in these cases, make it even more
difﬁcult to learn because the individual becomes euphoric
and wakeful, preventing the adequate amount of rest that is
required for memory consolidation.
Besides little scientiﬁc support to advocate
methylphenidate use by healthy individuals with no medical
indication, even fewer studies analyze its possible side effects.
Those that evaluate this issue describe the side effects as
benign, such as tachycardia not followed by hypertension.4
Only one study cited possible severe side effects, including
visual hallucinations, dyskinesias, triggering of mania syn-
dromes, and also Tourette’s syndrome.8 Furthermore, other
less severe drug-related side effects include vertigo, sleepi-
ness, headache, lack of appetite, nausea, anxiety, stomach
pain, and sleep disorders. No scientiﬁc article described the
possibility of pharmacological addiction, emotional distress,
and long-term intellectual deﬁcit.2
The opinion of college students about stimulating
medicine, its possible beneﬁts, and forms of use is based on
information obtained in the lay media and from the opinion of
friends.3 Therefore, the level of knowledge about the physio-
logical and psychological side effects and legal consequences
of its illicit use is below the expected, suggesting that this
topic has not been sufﬁciently discussed in the curriculum of
modern medical schools.6,9
Conclusion
Current literature does not present sufﬁcient evidence to
support methylphenidate use among healthy college stu-
dents in order to improve cognition. There is no evidence
that it enhances the capacity for memorization or associa-
tive learning. The drug appears to increase waking hours.
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Thus, expectations about its efﬁciency exceed its real bene-
ﬁts. In addition, users often fail to mention the side effects
of methylphenidate abuse. Finally, the development of clin-
ical, educational, and preventive strategies to reduce the
illicit prescription of psychostimulating agents should be
included in the curriculum of Brazilian universities and
colleges as an initiative of the faculty and the institu-
tion.
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